Hepatic Glucose Uptake During Euglycemic Hyperinsulinemia Associates With Glycemia During Oral Glucose Tolerance Test
Open Access
- 24 March 2025
- journal article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 9 (5) , bvaf054
Abstract
Context: Postprandial hepatic glycogen synthesis and glycolysis are reduced in hepatic insulin resistance. However, the physiologic interpretation of the reduction in hepatic glucose uptake (GU) during the gold-standard measurement of insulin sensitivity, hyperinsulinemic euglycemic clamp, in insulin resistance is unclear. This is because the peripheral route of glucose and insulin delivery during a clamp study differs greatly from the physiological route. Objective: We hypothesized that hepatic GU during hyperinsulinemic euglycemic clamp would predict glycemia during oral glucose tolerance test (OGTT). Design: We analyzed cross-sectional data of 120 individuals (70 men and 50 women) who did not have diabetes from the CMgene study cohort. Hepatic GU was measured with [18F]fluorodeoxyglucose ([18F]FDG) and positron emission tomography. Results: In a multiple regression analysis, hepatic GU, endogenous glucose production, insulin secretion capacity, and serum triglycerides predicted OGTT glucose area under the curve (P for all <.05), whereas skeletal muscle GU, the antilipolytic insulin index, and insulin clearance were not statistically significant predictors (P > .05). Conclusions: Hepatic GU measured during hyperinsulinemic euglycemic clamp is an independent predictor of OGTT glucose area under the curves even when accounting for well-known other factors affecting glycemic control. This finding supports the idea that insulin-mediated hepatic GU, and more broadly, first-pass glucose extraction, have a meaningful contribution to glycemic control. Thus, this measurement provides useful information about hepatic insulin sensitivity in the more physiologic conditions of the OGTT which may be useful when studying the pathophysiology of impaired glucose tolerance and when evaluating potential treatments for impaired glycemic control.Keywords
Funding Information
- Research Council of Finland (307402)
- Turku University Hospital (332151)
- Finnish Diabetes Research Foundation
- Finnish-Norwegian Medical Foundation
- Jalmari and Rauha Ahokas Foundation
- Emil Aaltonen Foundation
- University Hospital Foundation
- European Foundation for the Study of Diabetes
- Hospital District of Southwest Finland
- Orion Research Foundation
This publication has 64 references indexed in Scilit:
- Assessing Insulin Secretion by Modeling in Multiple-Meal TestsDiabetes, 2002
- Insulin Sensitivity of Suppression of Endogenous Glucose Production Is the Single Most Important Determinant of Glucose ToleranceDiabetes, 2001
- Type 2 Diabetes Impairs Splanchnic Uptake of Glucose but Does Not Alter Intestinal Glucose Absorption During Enteral Glucose FeedingDiabetes, 2001
- Independent Influence of Age on Basal Insulin Secretion in Nondiabetic HumansThe Journal of Clinical Endocrinology & Metabolism, 1999
- Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1993
- The effects of the menopause on insulin sensitivity, secretion and elimination in non‐obese, healthy womenEuropean Journal of Clinical Investigation, 1993
- Insulin resistance, secretion, and metabolism in users of oral contraceptives.The Journal of Clinical Endocrinology & Metabolism, 1992
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985
- The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative StudyDiabetes, 1985
- Influence of body composition on insulin clearanceClinical Physiology and Functional Imaging, 1985